Company profile
Regen BioPharma Inc CIK 1589150
Tickers
RGBP (OTC) · RGBPP (OTC)
Industry
Pharmaceutical Preparations
Headquarters
La Mesa, CA 91942
Fiscal year end
2025 (FY)
Key Financials
Revenue
$236.6K
Net income
-$1.27M
Total assets
$274.6K
Total liabilities
$6.56M
Stockholders' equity
-$6.28M
Cash & equivalents
$69.6K
Operating income
-$338.5K
Operating cash flow
-$383.6K
Capital expenditures
—
Fiscal year 2025, via 10-K filed 2025-12-30. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-143.1%
Net margin
-538.8%
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
2,387.2%
Equity / assets
-2,287.2%
CapEx / revenue
—
Operating cash flow / net income
0.30×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
$236.6K
-$1.27M
$274.6K
$6.56M
-$6.28M
2024
$236.6K
-$668.3K
$161.1K
$5.38M
-$5.22M
2023
$126.6K
$1.16M
$353.6K
$5.46M
-$5.10M
2022
$125.5K
$2.44M
$559.0K
$8.60M
-$8.04M
2021
$61.2K
-$6.77M
$1.21M
$14.70M
-$13.49M
Company Details
SIC code
2834
State of incorporation
NV
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-17
Financials filed via
Form 10-K
filed 2025-12-30
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
La Mesa, CA 91942
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:17 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.